期刊
PLOS BIOLOGY
卷 6, 期 2, 页码 240-252出版社
PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pbio.0060017
关键词
-
资金
- NICHD NIH HHS [R01 HD039899, HD-039899] Funding Source: Medline
- NINDS NIH HHS [R01 NS052842, NS052842] Funding Source: Medline
Amyloids are highly organized protein aggregates that are associated with both neurodegenerative diseases such as Alzheimer disease and benign functions like skin pigmentation. Amyloids self-polymerize in a nucleation-dependent manner by recruiting their soluble protein/peptide counterpart and are stable against harsh physical, chemical, and biochemical conditions. These extraordinary properties make amyloids attractive for applications in nanotechnology. Here, we suggest the use of amyloids in the formulation of long-acting drugs. It is our rationale that amyloids have the properties required of a long-acting drug because they are stable depots that guarantee a controlled release of the active peptide drug from the amyloid termini. This concept is tested with a family of short-and long-acting analogs of gonadotropin-releasing hormone ( GnRH), and it is shown that amyloids thereof can act as a source for the sustained release of biologically active peptides.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据